AbbVie (ABBV) Other Non-Current Liabilities (2012 - 2026)
AbbVie (ABBV) recorded Other Liabilities of $34.66 billion in Q3 2026, up 9.5% from $31.66 billion a year earlier and up 0.2% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie reported Other Liabilities of $32.57 billion, up 8.1% from FY2024.
- Annual Other Liabilities has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
- Across earlier years, Other Liabilities came in at $30.13 billion in FY2024 (-6.8%), $32.33 billion in FY2023 (+5.5%), $30.66 billion in FY2022 (+6.8%) and $28.7 billion in FY2021 (+4.0%).
- The Q3 2026 figure is the highest quarterly Other Liabilities in data going back to Q4 2012.
- On a year-over-year basis, Other Liabilities has increased for four consecutive quarters, with growth averaging 2.2% over the last eight quarters.
- Peak year-over-year performance for Other Liabilities in the last five years was growth of 15.1% in Q1 2023, against a decline of 6.8% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $34.6 billion (Q2 2026), $34.11 billion (Q1 2026) and $32.57 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.66 Bn |
| Jun 30, 2026 | 34.60 Bn |
| Mar 31, 2026 | 34.11 Bn |
| Dec 31, 2025 | 32.57 Bn |
| Sep 30, 2025 | 31.66 Bn |
| Jun 30, 2025 | 32.04 Bn |
| Mar 31, 2025 | 31.19 Bn |
| Dec 31, 2024 | 30.13 Bn |
| Sep 30, 2024 | 33.03 Bn |
| Jun 30, 2024 | 32.43 Bn |
| Mar 31, 2024 | 32.78 Bn |
| Dec 31, 2023 | 32.33 Bn |
| Sep 30, 2023 | 31.64 Bn |
| Jun 30, 2023 | 32.29 Bn |
| Mar 31, 2023 | 32.25 Bn |
| Dec 31, 2022 | 30.66 Bn |
| Sep 30, 2022 | 30.22 Bn |
| Jun 30, 2022 | 30.77 Bn |
| Mar 31, 2022 | 28.02 Bn |
| Dec 31, 2021 | 28.70 Bn |
API Access
AbbVie Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();